ConductScience.org, home

Gene · 623

NIH grants929

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleBDKRB1 papersNewest fiscal year
R01DA012864Mechanisms and Cellular Function of Opioid Receptor Endocytosis12025
R01DA036596Regulation of Neuronal GPCR Signaling12025
R01DC018584Preclinical trial for dysarthria treatment in Parkinson disease12025
R01DE018304ART Modulation of Viral Pathogenesis12025
R01ES027778Mechanism for arsenic induced carcinogenesis12025
R01EY011500Structure-function studies of visual arrestin12025
R01EY018139Molecular Organization of the First Visual Synapse12025
R01EY022359eNOS-Dependent Mechanoregulation of Intraocular Pressure12025
R01EY032561Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurity12025
R01HD090927Detecting pathogen and host factors on extracellular vesicles for pediatric TB diagnosis and management12025
R01HL068835Characterization of an isoform specific anticoagulant function of TFPI-alpha12025
R01HL091469Cysteine oxidation in the heart12025
R01HL131517Sex-specific arrhythmogenic mechanisms of atrial fibrillation12025
R01HL134846Purinergic modulation of the autoimmune vascular phenotype12025
R01HL136292Cardiomyocyte TRPV4 and Angiotensin-II induced ventricular arrhythmia with aging12025
R01HL136389The Role of Gasdermin-D/Interleukin-1 Nexus in Atrial Arrhythmogenesis12025
R01HL137112Purinergic Regulation of Veinous Endothelial Permeability12025
R01HL149762Formyl peptide receptor activation induces vascular plasticity and remodeling inhypertension12025
R01HL155095Airway Structural Cells and Corticosteroid Resistance in Asthma12025
R01HL155107L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/623/grants?page=4